We report a case in which switching to liraglutide therapy ameliorated both the symptoms of insulin allergy with hypereosinophilia and the characteristics of insulin antibodies in patients with type 2 diabetes mellitus. This evidence concerns the gene INS and type 2 diabetes mellitus.